(September 11, 2018, 2:33 PM EDT) -- CHICAGO — AbbVie Inc., Abbott Laboratories and two related entities have entered into a confidential term sheet regarding a potential global settlement of claims involving AndroGel testosterone replacement therapy, according to a Sept. 10 case management order by the Illinois federal judge overseeing the testosterone multidistrict litigation (In Re: Testosterone Replacement Therapy Products Liability Litigation, MDL Docket No. 2545, No. 14-1748, N.D. Ill.)....